文献速递腹部MR

混合型肝癌-胆管癌组织病理成分与MRI特征及预后的相关性

Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
PubMed 文献 · Eur Radiol · 2022-08-17

本研究回顾性纳入106例经组织病理学证实的混合型肝癌-胆管癌(cHCC-CCA)患者,比较不同HCC成分比例亚组的MRI特征及临床病理表现,并分析HCC成分比例对无复发生存(RFS)和总生存(OS)的预测价值。结果显示,LI-RADS 4/5类在HCC成分>50%、>70%、>90%的cHCC-CCA中更常见;HCC成分>70%的患者OS预后优于≤70%者。

要点

  • cHCC-CCA若MRI表现为LI-RADS 4/5类,提示HCC成分占比较高。
  • HCC成分>70%的cHCC-CCA患者总生存期优于≤70%者。
  • MRI LI-RADS分类有助于术前无创评估cHCC-CCA中HCC成分比例。

核心结论

  • cHCC-CCAs categorized as LR-4/5 are mainly composed of HCC component.
  • cHCC-CCAs with an HCC component > 70% are associated with better OS than those with an HCC component ≤ 70%.
  • These findings suggest that the proportion of HCC or CCA component can predict the prognosis of cHCC-CCA patients.

研究设计与样本

  • 回顾性纳入106例经组织病理学证实的cHCC-CCA患者,评估MRI特征及临床病理表现。
  • 按HCC成分比例分为不同亚组进行比较,采用Kaplan-Meier曲线及log-rank检验评估RFS和OS。
  • 采用Cox回归分析探讨HCC成分比例是否为RFS和OS的预测因素。

诊断标准与关键数值

  • LI-RADS 4/5类在HCC成分>50%的cHCC-CCA中更常见(OR=5.559,p=0.018)。
  • LI-RADS 4/5类在HCC成分>70%的cHCC-CCA中更常见(OR=4.031,p=0.008)。
  • LI-RADS 4/5类在HCC成分>90%的cHCC-CCA中更常见(OR=6.282,p=0.012)。
  • HCC成分>70%的cHCC-CCA患者OS预后更好(HR: 0.241,p=0.023)。

临床应用与阅片要点

  • 阅片时若cHCC-CCA表现为LI-RADS 4/5类,应提示HCC成分占比较高。
  • 报告cHCC-CCA时可根据LI-RADS分类间接提示HCC成分比例,辅助预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To distinguish MR features according to different proportions of the histopathological hepatocellular carcinoma (HCC) component and to investigate whether the proportion of the HCC component can predict the prognosis of patients with cHCC-CCA.

METHODS: The study enrolled 106 cHCC-CCA patients confirmed by histopathology. The MR imaging features and clinicopathological findings were retrospectively evaluated and compared between two subgroups with different proportions of the HCC component. The recurrence-free survival (RFS) and overall survival (OS) were evaluated using Kaplan-Meier survival curves and compared using the log-rank test. Moreover, whether the proportion of the HCC component was a predictor of RFS and OS was investigated using Cox regression analyses.

RESULTS: The Liver Imaging Reporting and Data System (LI-RADS) category 4/5 was more prevalent in cHCC-CCAs with an HCC component > 50% (odds ratio (OR) = 5.559, p = 0.018), 70% (OR = 4.031, p = 0.008), and 90% (OR = 6.282, p = 0.012) than in those with an HCC component ≤ 50%, 70%, and 90%, respectively. In addition, cHCC-CCAs with an HCC component > 70% (HR: 0.241, p = 0.023) had a better OS prognosis than those with an HCC component ≤ 70%.

CONCLUSIONS: cHCC-CCAs categorized as LR-4/5 are mainly composed of HCC component, and cHCC-CCAs with an HCC component > 70% are associated with better OS than those with an HCC component ≤ 70%. These findings suggest that the proportion of HCC or CCA component can predict the prognosis of cHCC-CCA patients.

KEY POINTS: • cHCC-CCAs categorized as LR-4/5 are mainly composed of HCC component. • cHCC-CCAs with an HCC component > 70% are associated with better OS than those with an HCC component ≤ 70%.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou, Lu, Wang, et al. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol. 2022. PMID: 35976399. doi:10.1007/s00330-022-09065-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。